{
    "code": "02025154",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025154",
    "time": "2016-11-18 20:39:20",
    "許可證字號": "衛署藥輸字第025154號",
    "註銷狀態": "已註銷",
    "註銷日期": "104\/03\/17",
    "註銷理由": "自請註銷",
    "有效日期": "104\/03\/09",
    "發證日期": "99\/03\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202515405",
    "中文品名": "委丹扎注射劑",
    "英文品名": "Vidaza for Injectable Suspension",
    "適應症": "治療骨髓增生不良症候群高危險性的病患High Risk MDS：頑固性貧血併有過量芽細胞 (RA with excess blasts, RAEB)、轉變中的頑固性貧血併有過量芽細胞 (RAEB in transformation, RAEB-T)、及慢性骨髓單核細胞性白血病 (chronic myelomonocytic leukemia, CMMoL)",
    "劑型": "243凍晶注射劑",
    "包裝": "100毫克小瓶裝 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "AZACITIDINE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "620117G076  賽基有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F460030200  BEN VENUE LABORATORIES,INC.",
        "製造廠廠址": "300 NORTHFIELD ROAD  BEDFORD OHIO 44146 U.S.A.",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F390023000  DHL Supply Chain Singapore Pte. Ltd.",
            "製造廠廠址": "7 Changi South Street 2#01-00 Xilin Districentre Singapore 486415",
            "製造廠公司地址": "",
            "製造廠國別": "SINGAPORE",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "F460658000  CELGENE CORPORATION",
            "製造廠廠址": "86 MORRIS AVENUE, SUMMIT, NJ 07901, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1008400500",
            "成分名稱": "AZACITIDINE",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Vidaza for Injectable Suspension - Celgene___20110705.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025154&Seq=002&Type=9"
        },
        {
            "title": "20120823 Chinese leaflet Vidaza to TFDA___20120903.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025154&Seq=001&Type=9"
        },
        {
            "title": "Vidaza_Taiwan Label_for US Label_V2___20110609.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025154&Seq=004&Type=8"
        },
        {
            "title": "Vidaza for Injectable Suspension - Celgene___20110705.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025154&Seq=003&Type=8"
        },
        {
            "title": "L___20110609.v02_VID-TW.PDF",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025154&Seq=002&Type=8"
        },
        {
            "title": "Label-C___20110609.v02VID100-TW.PDF",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025154&Seq=001&Type=8"
        }
    ]
}